Hospital study tracks eye drop risks in 1,000 patients
NCT ID NCT07178600
First seen Jun 26, 2026 · Last updated Jun 26, 2026 · Updated 1 time
Summary
This study will monitor 1,000 hospitalized patients who receive tropicamide/phenylephrine eye drops, commonly used to dilate pupils before eye surgery. Researchers will measure vital signs and ask about side effects at several time points after the drops are given. The goal is to identify which patients are more likely to have adverse reactions, such as high blood pressure or eye discomfort.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
tropicamide/phenylephrine eye drops
What this could lead to
If successful, this could help doctors predict and prevent side effects from these common eye drops in hospitalized patients.
What could go wrong
This is an observational study, not a treatment trial. It only looks for patterns, so it won't directly improve care or test a new therapy.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPERTENSION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Instituto de Oftalmología FAP Conde de Valenciana, IAP Sede Centro
RECRUITINGMexico City, Mexico Ciy, 06800, Mexico
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••